CCL2 and nephrolithiasis: In glyoxylic acid-induced nephrolithiasis murine models, CCR2 inhibitors significantly reduce tubular epithelial injury and crystal deposition, likely through disrupting the CCL2/CCR2-axis-mediated cross-talk between crystal-laden tubular cells and pro-inflammatory macrophages [42].